Ignasi Belda is cofounder and chairman of Twenty50 and CEO of MiWendo Solutions. Between 2016 and 2018, he was general manager of the research center Parque Científico de Barcelona. He has founded and sold four biotechnological companies: SOM Innovation Biotech, Intelligent Pharma, S.L. (Spain), Intelligent Pharma, L.L.C (USA) and BioCloun Research. He has taken part in many research projects at the Institut de Recerca Biomèdica, the University of Illinois in USA and AstraZeneca R&D in Sweden. In recognition of his career, he received the Príncipe de Girona award in 2014. Ignasi holds a degree in computer science from the Ramon Llull University, a doctor’s degree in biomedicine from the Polytechnic University of Catalonia, and is currently studying to earn a doctor’s degree in law from the Universidad Oberta de Cataluña.